1. Home
  2. Mandates
  3. Vinge advises Xspray Pharma in connection with a directed share issue (3)

Mandate Vinge advises Xspray Pharma in connection with a directed share issue

October 23, 2020

Vinge has advised the pharmaceutical development company Xspray Pharma in connection with a directed share issue, whereby Xspray receives gross proceeds of approximately SEK 265 million.

The share issue was directed to a number of Swedish and international institutional investors on the basis of an accelerated bookbuilding process. The purpose of the share issue is inter alia to enhance the company’s financial position ahead of negotiating a deal pertaining to its lead product HyNap-Dasa and to continue to expand the company’s product portfolio.

Vinge’s team has consisted of Dain Hård Nevonen, Linnéa Sellström, Joel Magnusson and Linnea Petersson.

Insurance law and blockage of the Suez Canal

One of the largest container ships in the world is still blocking the Suez Canal, an event which can have significant global consequences. Even Swedish interested parties such as the Port of Gothenburg may also be affected by the situation. The running aground is a clear reminder of the vulnerability of global transport chains, and sheds light on a number of important insurance issues.
March 29, 2021

Vinge top-ranked by Chambers & Partners within ten practice areas

 Vinge would like to thank all the clients who have contributed with their time through the interview processes for Chambers’ annual rankings. We have today received the result, and we are delighted with top rankings in 13 areas and a significant number of individual rankings.
March 19, 2021

Vinge’s Managing Partner Maria-Pia Hope is chosen as one of the most powerful women in Swedish business by Dagens Industri

 Maria Pia Hope, Managing Partner at Vinge, stands out as one of the few lawyers on the list when Dagens Industri presents its list of the most powerful women in business.
March 08, 2021